Diagnostic Medical Systems S.A. (EPA:ALDMS)

EPA:ALDMS Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.14	5.34	4.76	4.39	4.2
Cash & Short-Term Investments	7.14	5.34	4.76	4.39	4.2
Cash Growth	33.78%	12.26%	8.41%	4.40%	147.24%
Accounts Receivable	11.1	7.48	6.52	5.87	6.79
Other Receivables	2.63	2.09	2.67	4.63	4.68
Receivables	13.73	9.57	9.19	10.5	11.48
Inventory	15.68	14.45	16.04	13.05	11.89
Prepaid Expenses	0.44	0.19	0.32	0.6	0.43
Other Current Assets	0.96	0.76	1.38	10.42	2.04
Total Current Assets	37.96	30.3	31.68	38.96	30.03
Property, Plant & Equipment	3.96	4.51	5.13	5.49	6.06
Long-Term Investments	0.03	0.03	0.03	0.97	3.99
Goodwill	8.02	8.02	4.65	0.97	4.04
Other Intangible Assets	0.52	0.56	0.68	2.09	0.75
Long-Term Deferred Charges	11.58	10.16	8.45	4.64	8.16
Other Long-Term Assets	0.45	0.37	0.52	0.78	-
Total Assets	62.52	53.95	51.14	53.89	53.03

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	14.03	10.85	10.41	11.04	9.71
Accrued Expenses	1.81	2	1.83	2.39	3.95
Short-Term Debt	5.29	3.88	3.78	1.34	0.07
Current Portion of Long-Term Debt	2.94	4.01	2.44	3.03	5.13
Current Portion of Leases	0.71	0.66	0.64	0.57	0.65
Current Income Taxes Payable	0.81	0.61	0.98	0.64	0.49
Current Unearned Revenue	0.73	0.08	0.42	0.12	0.43
Other Current Liabilities	1.3	1.41	1.52	5.29	1.26
Total Current Liabilities	27.63	23.5	22.02	24.41	21.68
Long-Term Debt	6.66	8.02	9.23	6.15	5.16
Long-Term Leases	3.12	3.51	3.97	4.28	4.87
Long-Term Unearned Revenue	2.37	2.37	1.59	0.53	-
Pension & Post-Retirement Benefits	0.34	0.29	0.23	0.2	0.3
Other Long-Term Liabilities	1.74	2.11	0.38	0.15	0.58
Total Liabilities	41.85	39.79	37.42	35.72	32.59

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	31.61	24.7	20.89	19.1	19.1
Additional Paid-In Capital	1.96	2.34	2.34	1.35	1.35
Retained Earnings	-0.17	-2.88	-4.95	-6.82	-3.88
Comprehensive Income & Other	-14.27	-11.33	-5.89	2.04	2.16
Total Common Equity	19.14	12.84	12.38	15.66	18.73
Minority Interest	1.53	1.33	1.34	2.51	1.71
Shareholders' Equity	20.66	14.16	13.72	18.17	20.44
Total Liabilities & Equity	62.52	53.95	51.14	53.89	53.03

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	18.73	20.07	20.06	15.37	15.87
Net Cash (Debt)	-11.59	-14.73	-15.3	-10.98	-11.67
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.47	-0.72	-0.88	-0.68	-0.72
Filing Date Shares Outstanding	25.92	20.85	17.63	16.12	16.12
Total Common Shares Outstanding	25.92	20.85	17.63	16.12	16.12
Working Capital	10.33	6.8	9.67	14.54	8.35
Book Value Per Share	0.74	0.62	0.70	0.97	1.16
Tangible Book Value	10.59	4.25	7.05	12.6	13.95
Tangible Book Value Per Share	0.41	0.20	0.40	0.78	0.87
Machinery	2.95	2.85	2.96	3.06	2.86
Construction In Progress	-	0.05	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 23, 2026

Data Sources Report a data error